课题基金 / 基金详情

SBIR Phase II: Scale-up Manufacturing of Nitric Oxide Nanotechnology for Healthcare Infections

SBIR Phase II: Scale-up Manufacturing of Nitric Oxide Nanotechnology for Healthcare Infections
SBIR 第二阶段:用于医疗感染的一氧化氮纳米技术的放大生产
批准号:
1127380
负责人:
Nathan Stasko
金额:
$50.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-11-01 至 2013-12-31
关键词:

项目摘要

项目成果

Nathan Stasko的其他基金

相似基金

相关文献

中文摘要
翻译
该小型企业创新研究(SBIR)第二阶段项目旨在开发扩大一氧化氮释放活性药物成分(API)生产所需的工艺和工程控制。 其中一个应用是糖尿病足溃疡的伤口愈合产品。 本项目将侧重于1)优化将释放一氧化氮的API规模化生产至可重现的1 kg批次所需的工艺参数,以及2)实施分析方法,以满足研究性新药(IND)申请的化学、生产和控制(CMC)部分的要求。 预期结果是能够生产大批量API的生产工艺,该工艺适用于糖尿病足溃疡伤口愈合产品或其他一氧化氮释放药物的IND提交。 该项目的更广泛/商业影响将是为治疗糖尿病足溃疡提供新的护理标准的潜力。 目前,还没有解决糖尿病足溃疡伤口愈合和感染的产品。 感染在糖尿病足溃疡中尤其成问题,这是由于缺乏正常的皮肤屏障功能、伤口暴露于外部环境的持续时间长(数月至数年)、限制炎性细胞迁移到感染部位的四肢血液循环不良、以及最近对生物膜形成的理解,生物膜形成保护细菌免受局部应用的抗微生物剂和全身施用的抗生素的影响。 释放一氧化氮的伤口愈合疗法具有解决糖尿病足溃疡感染和愈合的潜力。
英文摘要
This Small Business Innovation Research (SBIR) Phase II project aims to develop the process and engineering controls necessary to scale up the manufacturing of a nitric-oxide-releasing active pharmaceutical ingredient (API). One of the applications is a wound-healing product for diabetic foot ulcers. This project will focus on 1) optimizing the process parameters required to scale production of a nitric-oxide-releasing API to reproducible 1 kg batches, and 2) implementing the analytical methodologies to meet the requirements of the Chemistry, Manufacturing and Control (CMC) sections of an Investigational New Drug (IND) application. The expected outcome is a manufacturing process capable of producing large batches of the API that are suitable for an IND submission of a wound-healing product for diabetic foot ulcers or other nitric-oxide-releasing drug. The broader/commercial impacts of this project will be the potential to provide a new standard of care for the treatment of diabetic foot ulcers. Currently, there are no products that address both wound healing and infection in diabetic foot ulcers. Infection is particularly problematic in diabetic foot ulcers due to the lack of normal skin barrier function, long duration of wound exposure to the external environment (months to years), poor blood circulation to the extremities that limits the migration of inflammatory cells to the site of infection, and the recent understanding of biofilm formation which protects bacteria from topically applied antimicrobials and systemically administered antibiotics. Nitric-oxide-releasing wound-healing therapeutics have the potential of addressing both infection and healing in diabetic foot ulcers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase I: Scale-up Manufacturing of Nitric Oxide Nanotechnology for Healthcare Infections
  • 批准号:
    1013531
  • 项目类别:
    Standard Grant
  • 资助金额:
    $14.08万
  • 财政年份:
    2010
  • 负责人:
    Nathan Stasko
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究